Nautilus Biotechnology, Inc. (NAUT) Ownership

NASDAQ: NAUTTop holders, insider trades and short interest.

NAUT ownership summary

as of October 18, 2026
Institutions
43.0%
of shares outstanding
Insiders
32.02%
of shares outstanding
Shares outstanding
127.3M
Float
67.5M
shares available to trade
Short interest
9.21%
5.8M shares short
Days to cover
2.14
short interest up 41.4% vs prior month
  • Institutions 43.00%
  • Insiders 32.02%
  • Other investors 24.98%

NAUT top institutional holders

20 largest
Nautilus Biotechnology, Inc. top institutional holders
#Holder% of sharesSharesValueChangeReported
1Perceptive Advisors LLC9.14%11.6M$24.0M−960,000 (−7.6%)June 30, 2026
2Cercano Management LLC5.64%7.2M$14.8M—June 30, 2026
3BlackRock Inc2.11%2.7M$5.5M+2.5M (+1,331.9%)June 30, 2026
4Vanguard Capital Management, LLC2.00%2.5M$5.3M+4,382 (+0.2%)June 30, 2026
5Comprehensive Financial Management LLC1.73%2.2M$4.5M—June 30, 2026
6Citadel Advisors Llc1.49%1.9M$3.9M+1.9M (0.0%)June 30, 2026
7Geode Capital Management, LLC0.99%1.3M$2.6M+662,011 (+109.7%)June 30, 2026
8Acadian Asset Management LLC0.83%1.1M$2.2M+314,215 (+42.4%)June 30, 2026
9Hartland & Co0.70%893K$1.8M−1.4M (−61.7%)June 30, 2026
10Susquehanna International Group, LLP0.70%891K$1.8M+890,949 (0.0%)June 30, 2026
11Sentinel Trust CO Lba0.59%750K$1.5M—June 30, 2026
12Barclays PLC0.57%725K$1.5M+651,996 (+889.2%)June 30, 2026
13Renaissance Technologies Corp0.54%691K$1.4M+424,814 (+159.9%)June 30, 2026
14JPMorgan Chase & Co0.48%614K$1.3M+614,177 (0.0%)June 30, 2026
15State Street Corp0.44%560K$1.2M+343,238 (+158.7%)June 30, 2026
16Dimensional Fund Advisors, Inc.0.37%476K$980,239+146,721 (+44.6%)June 30, 2026
17Northern Trust Corp0.30%381K$785,342+274,223 (+256.3%)June 30, 2026
18HRT FINANCIAL LLC0.28%361K$743,810+295,819 (+453.3%)June 30, 2026
19Vanguard Fiduciary Trust Co0.28%353K$727,372+47,567 (+15.6%)June 30, 2026
20Vanguard Portfolio Management, LLC0.27%338K$695,761+337,748 (0.0%)June 30, 2026

Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 15 holders added 9.4M shares and 2 cut 2.4M.

NAUT top mutual fund and ETF holders

20 largest
Nautilus Biotechnology, Inc. top fund holders
#Holder% of sharesSharesValueChangeReported
1Vanguard MStar Total Stk Mkt Idx Invest1.52%1.9M$4.0M—August 31, 2026
2iShares Russell 2000 ETF1.05%1.3M$2.8M−15,488 (−1.1%)September 30, 2026
3JPMorgan Small Cap Value I0.50%632K$1.3M—August 31, 2026
4Fidelity Small Cap Index0.43%542K$1.1M−667 (−0.1%)July 31, 2026
5iShares Russell 2000 Value ETF0.42%536K$1.1M+812 (+0.2%)September 30, 2026
6Vanguard Russell 2000 ETF0.23%287K$591,368+5,640 (+2.0%)August 31, 2026
7iShares Micro-Cap ETF0.14%182K$375,888−1,258 (−0.7%)September 30, 2026
8BSF Systematic US Eq Abs Ret A2 USD0.11%136K$281,106—December 31, 2025
9VALIC Company I Small Cap Value0.10%124K$254,878−2,662 (−2.1%)August 31, 2026
10Schwab Small Cap Index0.10%121K$249,505—August 31, 2026
11Russell Inv US Small Cap Equity Y0.08%100K$206,795—August 31, 2026
12Fidelity Extended Market Index0.07%93K$192,406−502 (−0.5%)August 31, 2026
13iShares Russell 2000 Small-Cap Idx Instl0.07%93K$191,491—August 31, 2026
14Fidelity Total Market Index0.07%91K$188,401—August 31, 2026
15BrighthouseI JPMorgan Small Cap Value A0.07%91K$187,190+90,869 (0.0%)June 30, 2026
16EA Bridgeway Ultra-Small Company Mkt ETF0.06%75K$154,500—September 30, 2026
17Fidelity Series Total Market Index0.06%74K$151,585—August 31, 2026
18iShares Russell 2000 Growth ETF0.05%68K$139,425−86 (−0.1%)September 30, 2026
19Nuveen Small Cap Blend Idx R60.05%66K$136,376—August 31, 2026
20Fidelity Small Cap Value Index0.05%63K$129,316—July 31, 2026

Funds report holdings monthly or quarterly; dates differ by fund.

NAUT insider transactions

latest 8
Nautilus Biotechnology, Inc. insider transactions
DateNameTransactionPriceSharesValue
2026-03-04Sujal M PatelBuy$2.6125,000$65,250
2025-11-06Kentaro SuzukiBuy$1.494,000$5,960
2025-09-08Sujal M PatelBuy$0.6883,500$56,780
2025-09-05Sujal M PatelBuy$0.67116,500$78,055
2025-09-04Matthew B MurphyBuy$0.6420,000$12,800
2025-05-29Anna MowryBuy$0.7715,000$11,550
2025-05-12Parag MallickBuy$0.731,500$1,095
2025-05-08Parag MallickBuy$0.7312,000$8,760

Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.

NAUT shares outstanding

Shares outstanding

Year-end shares outstanding, adjusted for splits.

Who owns NAUT

Institutional investors own 43.0% of Nautilus Biotechnology's shares and insiders 32.02%. The largest holder is Perceptive Advisors LLC with 9.14% of the shares (11.6M), as of June 30, 2026. Among the top 20 institutions, 15 added shares and 2 reduced their stake in the latest filings. Short interest is 9.21% of the float, or 2.14 days of average trading volume. The share count rose 1,656.5% since 2018.

Related: NAUT analyst forecast, NAUT key metrics. See the NAUT stock overview for the latest quote and news.

NAUT ownership FAQ

Who owns the most Nautilus Biotechnology stock?

The largest shareholders of Nautilus Biotechnology are Perceptive Advisors LLC (9.14%), Cercano Management LLC (5.64%), BlackRock Inc (2.11%), Vanguard Capital Management, LLC (2.00%), Comprehensive Financial Management LLC (1.73%).

What percentage of Nautilus Biotechnology is owned by institutions?

Institutions hold 43.0% of Nautilus Biotechnology's shares outstanding; insiders hold 32.02%.

Which funds own Nautilus Biotechnology?

The largest fund holders of Nautilus Biotechnology are Vanguard MStar Total Stk Mkt Idx Invest (1.52%), iShares Russell 2000 ETF (1.05%), JPMorgan Small Cap Value I (0.50%), Fidelity Small Cap Index (0.43%), iShares Russell 2000 Value ETF (0.42%).

What is Nautilus Biotechnology's short interest?

5.8M shares of Nautilus Biotechnology were sold short, 9.21% of the float; at the average daily volume it would take 2.14 days to cover.

Are insiders buying or selling Nautilus Biotechnology?

Of the latest 8 reported insider transactions in Nautilus Biotechnology (since May 8, 2025), 8 were purchases and 0 were sales.

How many shares of Nautilus Biotechnology are outstanding?

Nautilus Biotechnology has 127.3M shares outstanding, of which 67.5M are in the public float.

Biotechnology: ownership